☰

Walter F. Riker - Publications

Affiliations: 
Cornell University, Ithaca, NY, United States 
Area:
Pharmacology
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1992 Okamoto M, Walewski JL, Artusio JF, Riker WF. Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs. Anesthesia and Analgesia. 75: 361-71. PMID 1324625 DOI: 10.1213/00000539-199209000-00008  0.528
1990 Riker WF, Okamoto M, Artusio JF. The interactions of ouabain with post-tetanic and facilitatory drug potentiations at cat soleus neuromuscular junctions in vivo. Neurochemical Research. 15: 457-65. PMID 2167459 DOI: 10.1007/BF00969933  0.434
1988 Roe RD, Riker WF, Standaert FG. Motor nerve ending disorder in myasthenia gravis. Neurology. 38: 293-7. PMID 2829056 DOI: 10.1212/Wnl.38.2.293  0.573
1986 Hartman GS, Fiamengo SA, Riker WF. Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology. 65: 405-13. PMID 3767039  0.406
1985 Sprouse JS, Baker T, Riker WF. Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations. The Journal of Pharmacology and Experimental Therapeutics. 235: 864-72. PMID 4078737  0.362
1985 Askari FK, Hartman GS, Fiamengo SA, Riker WF. Actions of neostigmine carbon isosteres on mammalian motor nerve terminals (MNTs) part II: Interactions with ion channels may lead to use dependent repetitive discharge (UDR) Federation Proceedings. 44: No. 2823.  0.367
1983 Hall ED, Riker WF, Baker T. Beneficial action of glucocorticoid treatment on neuromuscular transmission during early motor nerve degeneration. Experimental Neurology. 79: 488-96. PMID 6129995 DOI: 10.1016/0014-4886(83)90228-5  0.704
1982 Drakontides AB, Baker T, Riker WF. A morphological study of the effect of glucocorticoid treatment on delayed organophosphorus neuropathy. Neurotoxicology. 3: 165-77. PMID 6304583  0.432
1982 Baker T, Drakontides AB, Riker WF. Prevention of the organophosphorus neuropathy by glucocorticoids. Experimental Neurology. 78: 397-408. PMID 6291977 DOI: 10.1016/0014-4886(82)90058-9  0.441
1982 Sprouse J, Baker T, Riker WF. Differential effects of mineralo- and glucocorticoids on mammalian motor nerve terminals Federation Proceedings. 41: 6016.  0.531
1981 Storella RJ, Riker WF, Baker T. Effects of adrenalectomy on neostigmine-induced facilitation of mammalian motor nerve terminal function Federation Proceedings. 40: 148.  0.546
1979 Baker T, Riker WF, Zeldes G. A benzodiazepine-anticholinergic drug synergism in the prevention of stress-induced gastric mucosal erosion in mice. Journal of Clinical Pharmacology. 19: 409-14. PMID 314947 DOI: 10.1002/J.1552-4604.1979.Tb02501.X  0.302
1978 Glazer EJ, Baker T, Riker WF. The neuropathology of DFP at cat soleus neuromuscular junction. Journal of Neurocytology. 7: 741-58. PMID 731281 DOI: 10.1007/BF01205148  0.628
1978 Drakontides AB, Riker WF. Functional, pharmacologic, and ultrastructural correlates in degenerating rat motor nerve terminals. Experimental Neurology. 59: 112-23. PMID 627259 DOI: 10.1016/0014-4886(78)90205-4  0.596
1978 Baker T, Riker WF, Hall ED. Triamcinolone enhancement of cat soleus motor nerve terminal excitability Federation Proceedings. 37: No. 1914.  0.533
1977 Hall ED, Riker WF, Baker T. Glucocorticoid effects on the edrophonium responsiveness of normal and degenerating mammalian motor nerve terminals. Annals of Neurology. 2: 404-8. PMID 215074 DOI: 10.1002/ana.410020510  0.697
1977 Hall ED, Baker T, Riker WF. Glucocorticoid preservation of motor nerve function during early degeneration. Annals of Neurology. 1: 263-9. PMID 196542 DOI: 10.1002/ana.410010312  0.68
1977 Baker T, Riker WF, Hall ED. Effects of a single methylprednisolone dose on a facilitatory response of mammalian motor nerve. Archives of Neurology. 34: 349-55. PMID 193476 DOI: 10.1001/Archneur.1977.00500180043009  0.69
1977 Baker T, Hall ED, Riker WF. Glucocorticoid preservation of cat motor nerve terminal excitability in DFP neuropathy Pharmacologist. 19: No. 402.  0.54
1975 Riker WF, Baker T, Okamoto M. Glucocorticoids and mammalian motor nerve excitability. Archives of Neurology. 32: 688-94. PMID 1180732 DOI: 10.1001/archneur.1975.00490520058009  0.468
1975 Lowndes HE, Baker T, Riker WF. Motor nerve terminal response to edrophonium in delayed DFP neuropathy. European Journal of Pharmacology. 30: 69-72. PMID 1122938 DOI: 10.1016/0014-2999(75)90204-6  0.719
1974 Lowndes HE, Baker T, Riker WF. Motor nerve dysfunction in delayed DFP neuropathy. European Journal of Pharmacology. 29: 66-73. PMID 4435046 DOI: 10.1016/0014-2999(74)90171-X  0.706
1973 Bunn PA, Okamoto M, Riker WF. Further observations on subacute denervation and mammalian motor nerve terminal function. Neurology. 23: 12-20. PMID 4347059 DOI: 10.1212/Wnl.23.1.12  0.606
1971 Okamoto M, Longenecker HE, Riker WF, Song SK. Destruction of mammalian motor nerve terminals by black widow spider venom. Science (New York, N.Y.). 172: 733-6. PMID 4324667 DOI: 10.1126/Science.172.3984.733  0.592
1969 Riker WF, Okamoto M. Pharmacology of motor nerve terminals. Annual Review of Pharmacology. 9: 173-208. PMID 4307019 DOI: 10.1146/annurev.pa.09.040169.001133  0.547
1969 Okamoto M, Riker WF. Subacute denervation: a means of disclosing mammalian motor nerve terminals as critical sites of acetylcholine and facilitatory drug actions. The Journal of Pharmacology and Experimental Therapeutics. 166: 217-24. PMID 4304912  0.508
1969 Okamoto M, Riker WF. Motor nerve terminals as the site of initial functional changes after denervation. The Journal of General Physiology. 53: 70-80. PMID 4302630 DOI: 10.1085/Jgp.53.1.70  0.633
1967 Standaert FG, Riker WF. THE CONSEQUENCES OF CHOLINERGIC DRUG ACTIONS ON MOTOR NERVE TERMINALS Annals of the New York Academy of Sciences. 144: 517-533. DOI: 10.1111/j.1749-6632.1967.tb53791.x  0.591
1966 Riker WF. Actions of acetylcholine on mammalian motor nerve terminal. The Journal of Pharmacology and Experimental Therapeutics. 152: 397-416. PMID 5922310  0.545
1966 Riker WF, Standaert FG. The action of facilitatory drugs and acetylcholine on neuromuscular transmission. Annals of the New York Academy of Sciences. 135: 163-76. PMID 5221338 DOI: 10.1111/J.1749-6632.1966.Tb45470.X  0.327
1960 RIKER WF. Pharmacologic considerations in a reevaluation of the neuromuscular synapse. Archives of Neurology. 3: 488-99. PMID 13741664 DOI: 10.1001/archneur.1960.00450050008003  0.51
1957 RIKER WF, ROBERTS J, STANDAERT FG, FUJIMORI H. The motor nerve terminal as the primary focus for drug-in-duced facilitation of neuromuscular transmission. The Journal of Pharmacology and Experimental Therapeutics. 121: 286-312. PMID 13481851  0.516
Show low-probability matches.